StockWatch
·
HomeLiveReports
Pharmaceuticals
Board Meeting6 Nov 2026, 11:02 am

Medicamen Biotech Board Meeting on Nov 13, 2026 for Unaudited Results

AI Summary

Medicamen Biotech Limited has announced that its Board of Directors will convene on November 13, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The meeting will cover both standalone and consolidated results. Additionally, the company has closed its trading window from October 01, 2026, which will reopen 48 hours after the financial results are declared, in compliance with SEBI's insider trading regulations.

Key Highlights

  • Board meeting scheduled for November 13, 2026.
  • To approve unaudited financial results for Q2 FY27.
  • Results will be standalone and consolidated.
  • Trading window closed from October 01, 2026.
  • Trading window reopens 48 hours post results declaration.
View BSE Filing
MEDICAMEQ
Pharmaceuticals
MEDICAMEN BIOTECH LTD.-$

Price Impact

More from MEDICAMEQ

Shareholding26 Oct, 4:14 pm

Medicamen Biotech: Shivalik Rasayan Acquires 3.56% Stake

Corporate Action23 Oct, 12:02 pm

Medicamen Biotech Allots 5 Lakh Shares on Warrant Conversion

Insider Trading30 Sept, 5:10 pm

Sanjay Bansal Sells 70,000 Medicamen Biotech Shares

More in Board Meeting

SICAPIT18m ago

SI Capital Board Meeting on Nov 12 to Approve Q2 FY27 Results

AXELPOLY48m ago

Axel Polymers Board Meeting on Nov 13 to Approve Q2 FY27 Results

SHRIKRISH3h ago

Shri Krishna Devcon Board Meeting on Nov 14 to Approve Results